Health Canada
- Status: approved
🇨🇦 IPV at 6 and fIPV at 22 weeks, RotaTeq in Canada
IPV at 6 and fIPV at 22 weeks, RotaTeq (IPV at 6 and fIPV at 22 weeks, RotaTeq) regulatory status in Canada.
Marketing authorisation
IPV at 6 and fIPV at 22 weeks, RotaTeq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is IPV at 6 and fIPV at 22 weeks, RotaTeq approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for IPV at 6 and fIPV at 22 weeks, RotaTeq in Canada?
Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.